Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
Neurology
|
April 9, 2026
The Muscle Cramp Impact Index: A Patient-Centered Scale for the Assessment of Muscle Cramps
Hans D Katzberg, Vera Bril, Lorne Zinman, et al.
Diabetologia
|
June 19, 2016
The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes
David Cherney, Søren S Lund, Bruce A Perkins, et al.
Angiology
|
February 1, 2020
Effect of Uric Acid-Lowering Agents on Cardiovascular Outcome in Patients With Heart Failure: A Systematic Review and Meta-Analysis of Clinical Studies
Mehmet Kanbay, Baris Afsar, Dimitrie Siriopol, et al.
Diabetes Care
|
August 3, 2019
The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes
Daniël H van Raalte, Petter Bjornstad, Frederik Persson, et al.
Cytokine
|
August 2, 2017
Relationship between serum inflammatory markers and vascular function in a cohort of adolescents with type 1 diabetes
Etienne Sochett, Damien Noone, Michael Grattan, et al.
Journal of the American Society of Nephrology : JASN
|
May 25, 2024
Effect of Avenciguat on Albuminuria in Patients with CKD: Two Randomized Placebo-Controlled Trials
Hiddo J L Heerspink, David Cherney, Abdul Halim Abdul Gafor, et al.
Journal of the American Society of Nephrology : JASN
|
September 4, 2024
Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses
Tariq Jamal Siddiqi, David Cherney, Hasan Fareed Siddiqui, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 1, 2022
Moving from Evidence to Implementation of Breakthrough Therapies for Diabetic Kidney Disease
Katherine R Tuttle, Leslie Wong, Wendy St Peter, et al.
Journal of the American Society of Nephrology : JASN
|
June 13, 2025
Kidney Parameters with Tirzepatide in Obesity with or without Type 2 Diabetes
Hiddo J L Heerspink, Allon N Friedman, Petter Bjornstad, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 13, 2026
Combination Treatment for Management of Chronic Kidney Disease and Type 2 Diabetes: A Review and Practical Guidance
Mai Mohsen, Tae Won Yi, Labib Faruque, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
Neurology
|
April 9, 2026
The Muscle Cramp Impact Index: A Patient-Centered Scale for the Assessment of Muscle Cramps
Hans D Katzberg, Vera Bril, Lorne Zinman, et al.
Diabetologia
|
June 19, 2016
The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes
David Cherney, Søren S Lund, Bruce A Perkins, et al.
Angiology
|
February 1, 2020
Effect of Uric Acid-Lowering Agents on Cardiovascular Outcome in Patients With Heart Failure: A Systematic Review and Meta-Analysis of Clinical Studies
Mehmet Kanbay, Baris Afsar, Dimitrie Siriopol, et al.
Diabetes Care
|
August 3, 2019
The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes
Daniël H van Raalte, Petter Bjornstad, Frederik Persson, et al.
Cytokine
|
August 2, 2017
Relationship between serum inflammatory markers and vascular function in a cohort of adolescents with type 1 diabetes
Etienne Sochett, Damien Noone, Michael Grattan, et al.
Journal of the American Society of Nephrology : JASN
|
May 25, 2024
Effect of Avenciguat on Albuminuria in Patients with CKD: Two Randomized Placebo-Controlled Trials
Hiddo J L Heerspink, David Cherney, Abdul Halim Abdul Gafor, et al.
Journal of the American Society of Nephrology : JASN
|
September 4, 2024
Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses
Tariq Jamal Siddiqi, David Cherney, Hasan Fareed Siddiqui, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 1, 2022
Moving from Evidence to Implementation of Breakthrough Therapies for Diabetic Kidney Disease
Katherine R Tuttle, Leslie Wong, Wendy St Peter, et al.
Journal of the American Society of Nephrology : JASN
|
June 13, 2025
Kidney Parameters with Tirzepatide in Obesity with or without Type 2 Diabetes
Hiddo J L Heerspink, Allon N Friedman, Petter Bjornstad, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 13, 2026
Combination Treatment for Management of Chronic Kidney Disease and Type 2 Diabetes: A Review and Practical Guidance
Mai Mohsen, Tae Won Yi, Labib Faruque, et al.
Page
of 6